Bill Ackman’s hedge fund posts dismal returns as Valeant craters

The news just keeps getting worse for activist investor Bill Ackman. Ackman’s hedge fund Pershing Square Holdings is down 21.2% year to date, battered by the plunge in Valeant Pharmaceuticals International Inc., one of its biggest holdings.